Celgene Research Associate, Drug Substance Development in Summit, New Jersey
Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.
Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence, and love of challenge. With a presence in more than 70 countries - and growing - we look for talented people to grow our business, advance our science, and contribute to our unique culture.
Core member of a dynamic, scientifically driven team dedicated to the discovery and robust engineering development and scale-up of chemical syntheses and processes for active pharmaceutical compounds.
Assist senior researchers in developing scalable chemical manufacturing processes by planning, executing, interpreting, and clearly documenting experiments.
Assist with the manufacture of development candidates for pre-IND studies.
Support chemical engineering process development experiments, process scale-up, and CRO/CMO support.
Responsible for hands on laboratory and kilo lab work.
Responsible for supporting crystallization development and experiments.
Remaining current with required GMP training and qualifications.
Apply cGMP principles by following internal standard operating procedures (SOPs), work practices (WPs), and regulatory requirements.
Assume departmental responsibilities for assigned projects and equipment.
Maintain safety, regulatory, and compliance standards as they relate to the development of pharmaceuticals.
Prepare technical reports and oral presentations.
B.S. in Chemical Engineering or Related Field
Strong laboratory skills and fundamental knowledge of chemical engineering.
Proficiency in the use of HPLC, GC, Crystal 16 and EasyMax. Experience with process automation platforms, DSC, TGA, and/or XRD are a plus.
Ability and drive to learn and implement relevant principles of chemical engineering, material science, analytical chemistry, and regulatory guidelines.
Strong interpersonal skills and the ability to work in a fast paced, multidisciplinary, matrixed environment.
Ability to work independently or in a team under deadline. Strong verbal and written communication skills are essential.
Crystallization development or kilo lab or pilot plant experience is desired.
Familiarity with GMP/GLP practices and standards are a plus
Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.